showed a trendp = 0.078
In contrast, the remyelination group, which received the first dose of BrdU on the day when the cuprizone treatment was stopped and then survived for 14 more days, showed a trend (p = 0.078) for fewer BrdU + cells in comparison to the controls only in the GL plus SGZ (Fig. 8 B,C).